Christine Lundgren Selected Research

Triple Negative Breast Neoplasms

12/2020

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Lundgren Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 04/2024 - 07/2018
2	Neoplasms (Cancer) 01/2023 - 11/2019
1	Triple Negative Breast Neoplasms 12/2020

Drug/Important Bio-Agent (IBA)

4	Tamoxifen FDA LinkGeneric 04/2024 - 12/2020
3	Hormones (Hormone)IBA 04/2024 - 07/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2019
2	Phenobarbital (Luminal)FDA Link 05/2022 - 11/2019
1	Estrogen ReceptorsIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	ParaffinIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2022
1	Adjuvant Chemotherapy 05/2022
1	Therapeutics 07/2018